Transgender research papers

Transition related healthcare

Masculinization

Hormone replacement therapy

• (April 2020) Testosterone, Cortisol, and Secretory immunoglobulin-A Within a Single Day and Across Two Sequential Days Among Trans- And Cis-Gender Men.

• (March 2020) Impact of Exogenous Testosterone on Reproduction in Transgender Men.

• (February 2020) The effect of testosterone on ovulatory function in transmasculine individuals.

• (October 2019) A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.

• (August 2019) Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate.

• (June 2019) The effect of testosterone therapy on personality traits of trans men: a controlled prospective study in Germany and Switzerland.

• (April 2019) Longitudinal Case Study of Transgender Voice Changes Under Testosterone Hormone Therapy.

• (July 2018) Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration.*

• (July 2018) Hormone Therapy for Transgender Men.

• (June 2018) Exogenous Testosterone Does Not Induce Or Exacerbate The Metabolic Features Associated With PCOS Among Transgender Men.

• (May 2018) Recommendations for the Use of Testosterone in Male Transgender.

• (March 2018) Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study.

• (February 2018) Severe Secondary Polycythemia in a Female-to-Male Transgender Patient While Using Lifelong Hormonal Therapy: A Patient’s Perspective.

• (November 2017) Cross-sex testosterone therapy in ovariectomized mice: addition of low-dose estrogen preserves bone architecture.

• (November 2017) Relationship between testosterone in serum, saliva and urine during treatment with intramuscular testosterone undecanoate in gender dysphoria and male hypogonadism.

• (October 2017) The Response of the Menstrual Cycle to Initiation of Hormonal Therapy in Transgender Men.

• (September 2017) Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review.

• (July 2017) Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients.

• (April 2017) Testosterone therapy for transgender men.

• (March 2017) Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male).

• (February 2016) Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.

• (October 2015) High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People.

• (May 2015) Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.

• (February 2015) Testosterone treatment and MMPI-2 improvement in transgender men: a prospective controlled study.

• (September 2013) Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder.

• (October 2012) Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder.

• (January 2012) Associations between transition-specific stress experience, nocturnal decline in ambulatory blood pressure, and C-reactive protein levels among transgender men.

• (March 2010) Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals.

• (September 2009) Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals.